Projects funded by the NCN
Impact of the CDK4/6 targeted degradation by PROTACs on immune checkpoint signaling in cancer
2021/43/B/NZ7/03170
Keywords:
immune checkpoint signaling PD-L1 CDK4 cancer PROTAC
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- ST4_9: Biological chemistry
- NZ6_2: Clinical immunology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Wydział Chemii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 22 - announced on 2021-09-15
Amount awarded: 3 551 670 PLN
Project start date (Y-m-d): 2022-07-27
Project end date (Y-m-d): 2026-07-26
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.